Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer prediction test based on the patient’s individual risk; and DenSeeMammo, a breast density measurement software. Predilife S.A. was incorporated in 2004 and is headquartered in Villejuif, France.
Metrics to compare | ALPRE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALPREPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.2x | −3.5x | −0.5x | |
PEG Ratio | −0.16 | 0.02 | 0.00 | |
Price/Book | −0.8x | 2.4x | 2.6x | |
Price / LTM Sales | 16.5x | 17.2x | 3.3x | |
Upside (Analyst Target) | - | 121.4% | 45.5% | |
Fair Value Upside | Unlock | 1.2% | 5.1% | Unlock |